1.0ケンブリッジコンサルタンツhttps://www.cambridgeconsultants.com/jpmattjacksonhttps://www.cambridgeconsultants.com/jp/author/mattjackson/Breakthrough next-generation inhaler for Chiesirich600338<blockquote class="wp-embedded-content" data-secret="3rCVN6qNbg"><a href="https://www.cambridgeconsultants.com/jp/project/breakthrough-next-generation-inhaler-for-chiesi/">Breakthrough next-generation inhaler for Chiesi</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.cambridgeconsultants.com/jp/project/breakthrough-next-generation-inhaler-for-chiesi/embed/#?secret=3rCVN6qNbg" width="600" height="338" title="“Breakthrough next-generation inhaler for Chiesi” — Cambridge Consultants" data-secret="3rCVN6qNbg" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.cambridgeconsultants.com/wp-includes/js/wp-embed.min.js
</script>https://www.cambridgeconsultants.com/wp-content/uploads/2023/11/Featured_Client-Story_Chiesi-next-generation-inhaler.jpeg15001160Chiesi Farmaceutici came to us with the brief of creating a novel, next-generation dry powder inhaler (DPI) that could compete with the market leaders. In 2013, that vision was realised as NEXThaler launched in Germany. Since then, millions of units have been sold throughout Europe, with distribution continuing to expand globally.